Visiongain reports are rubbish. They are based on spurious desk research and have not the least currency in expert pharmaceutical circles. The cannabinoid report has been around for almost a year. Visiongain produces these reports at negligible cost and hopes that some mug is prepared to fork out for a copy.
How can you give any credence to a report that contains the quote shown in post 5426? We'll be lucky if Sativex sales in 2005 exceed $2m, let alone $200m.
Visiongain is based in that epicentre of intellectual and academic research, Tooting High Street.
GW Pharm stock quotes
GW Pharm stock charts
Follow this thread
